These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26569432)

  • 1. Dendritic cells in brain diseases.
    Ludewig P; Gallizioli M; Urra X; Behr S; Brait VH; Gelderblom M; Magnus T; Planas AM
    Biochim Biophys Acta; 2016 Mar; 1862(3):352-67. PubMed ID: 26569432
    [No Abstract]   [Full Text] [Related]  

  • 2. MRI of animal models of brain disease.
    van der Weerd L; Thomas DL; Thornton JS; Lythgoe MF
    Methods Enzymol; 2004; 386():149-77. PubMed ID: 15120250
    [No Abstract]   [Full Text] [Related]  

  • 3. Myeloid derived suppressor cells in inflammatory conditions of the central nervous system.
    Melero-Jerez C; Ortega MC; Moliné-Velázquez V; Clemente D
    Biochim Biophys Acta; 2016 Mar; 1862(3):368-80. PubMed ID: 26527182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stop inflammation and you stop neurodegeneration in MS - YES.
    Yong HY; Yong VW
    Mult Scler; 2017 Sep; 23(10):1320-1321. PubMed ID: 28463075
    [No Abstract]   [Full Text] [Related]  

  • 5. Stop inflammation and you stop neurodegeneration in MS - NO.
    Kalincik T
    Mult Scler; 2017 Sep; 23(10):1321-1323. PubMed ID: 28463073
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicine: Collateral damage repaired.
    Steinman L
    Nature; 2003 Apr; 422(6933):671-2. PubMed ID: 12700743
    [No Abstract]   [Full Text] [Related]  

  • 7. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression.
    Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z
    J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of dendritic cells in neurodegenerative diseases.
    Iribarren P; Cui YH; Le Y; Wang JM
    Arch Immunol Ther Exp (Warsz); 2002; 50(3):187-96. PubMed ID: 12098934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines as Mediators of Neuroinflammation in Experimental Autoimmune Encephalomyelitis.
    Gogoleva VS; Atretkhany KN; Drutskaya MS; Mufazalov IA; Kruglov AA; Nedospasov SA
    Biochemistry (Mosc); 2018 Sep; 83(9):1089-1103. PubMed ID: 30472948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology meets neuroscience--opportunities for immune intervention in neurodegenerative diseases.
    Lynch MA; Mills KH
    Brain Behav Immun; 2012 Jan; 26(1):1-10. PubMed ID: 21664452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting neuro-immune communication in neurodegeneration: Challenges and opportunities.
    Deczkowska A; Schwartz M
    J Exp Med; 2018 Nov; 215(11):2702-2704. PubMed ID: 30301785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide plays a key role in the suppressive activity of tolerogenic dendritic cells.
    Verinaud L; Issayama LK; Zanucoli F; de Carvalho AC; da Costa TA; Di Gangi R; Bonfanti AP; Ferreira IT; de Oliveira AL; Machado DR; Thomé R
    Cell Mol Immunol; 2015 May; 12(3):384-6. PubMed ID: 25308751
    [No Abstract]   [Full Text] [Related]  

  • 16. Dendritic cells in inflammatory responses in the CNS.
    Matyszak MK; Perry VH
    Adv Exp Med Biol; 1997; 417():295-9. PubMed ID: 9286376
    [No Abstract]   [Full Text] [Related]  

  • 17. New developments in understanding and treating neuroinflammation.
    Infante-Duarte C; Waiczies S; Wuerfel J; Zipp F
    J Mol Med (Berl); 2008 Sep; 86(9):975-85. PubMed ID: 18196212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.
    Shalaby SM; Sabbah NA; Saber T; Abdel Hamid RA
    IUBMB Life; 2016 Feb; 68(2):106-15. PubMed ID: 26757144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
    Croxford AL; Spath S; Becher B
    Trends Immunol; 2015 Oct; 36(10):651-662. PubMed ID: 26431942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
    J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.